# FDA Inspection 1312774 - Seaco National Corp. DBA Southeast Pet - April 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/seaco-national-corp-dba-southeast-pet/c8902faa-f95a-49f3-9652-e6afb06022a5
Source feed: FDA_Inspections

> FDA Inspection 1312774 for Seaco National Corp. DBA Southeast Pet on April 17, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1312774
- Company Name: Seaco National Corp. DBA Southeast Pet
- Inspection Date: 2026-04-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Monitoring of Marketed Animal Drugs, Feed, and Devices
- Product Type: Animal Drugs & Feeds
- Office Name: Atlanta District Office

## Related Documents

- [FDA Inspection 1175527 - 2022-07-12](https://www.keypedia.com/records/fda_inspections/seaco-national-corp-dba-southeast-pet/e60bf987-242c-465e-9bf0-bb69f890fb94)
- [FDA Inspection 1127741 - 2020-08-26](https://www.keypedia.com/records/fda_inspections/seaco-national-corp-dba-southeast-pet/99791982-360b-45bc-a5f6-c5aff1c05141)

Company: https://www.keypedia.com/companies/seaco-national-corp-dba-southeast-pet/3dca540e-3cf0-4637-8f83-f9400e5fb578

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7